You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Bortezomib monotherapy for relapsed multiple myeloma
Technology appraisal guidance
Reference number:
TA129
Published:
23 October 2007
Guidance
Tools and resources
Information for the public
History
Expert statements
Jackson
Jago
Morgan
This page was last updated:
30 March 2010
Back to top